07:00 , Aug 22, 2016 |  BC Week In Review  |  Company News

Trovagene sales and marketing update

Trovagene said Blue Cross Blue Shield (BCBS) of Illinois will cover Trovagene’s Trovera liquid biopsy tests. The biotech markets Trovera EGFR, a non-invasive molecular diagnostic to detect EGFR exon 19 deletions and exon 20...
07:00 , Apr 28, 2014 |  BC Week In Review  |  Clinical News

BRAF V600E oncogene mutation assay: Clinical trial data

Researchers at the University of Texas MD Anderson Cancer Center reported data from a prospective study in 33 patients whose biopsies had previously tested positive for BRAF V600E mutations by a CLIA-certified laboratory showed...